NCT07624682

Brief Summary

Traditional medical education has long emphasized one-way transmission of theoretical knowledge, which presents limitations in the systematic cultivation of clinical reasoning skills among medical students. Miller's pyramid of clinical competence emphasizes the gradual transformation from theoretical knowledge to clinical practice ability. Case-based learning (CBL), as a teaching method centered on real or simulated clinical cases, is a key strategy to address the above limitations. Artificial intelligence (AI)-assisted clinical reasoning training tools can overcome time and space constraints, and offer students repeatable, adaptive, and real-time feedback case training, thereby reinforcing the sustained role of CBL in clinical reasoning development. Currently, it still lacks high-quality evidence from randomized controlled trials on the impact of AI agents on medical students' clinical reasoning skills. This study plans to evaluate the impact of an AI clinical reasoning training agent on students' clinical reasoning training outcomes and CBL learning experience. Primary Objective: To evaluate the impact of the AI agent on student learning outcomes (course examination scores and clinical reasoning test scores). Secondary Objective: To investigate students' AI acceptance (perceived usefulness, perceived ease of use, satisfaction, and intention to use). This study adopts a two-arm parallel cluster randomized controlled trial design. The trial is designed and reported in accordance with the CONSORT statement. The study population will recruit Class of 2021 medical students (8-year program) from Peking Union Medical College and Class of 2020 medical students (8-year program) from Tsinghua University School of Medicine. Both cohorts are officially enrolled in the "Comprehensive Clinical Course" for the 2025-2026 academic year, have consistent foundational knowledge in basic medicine and diagnostics, and are in the phase of clinical medicine theory learning, not yet having entered clinical practice. Using PASS 2025 software, the sample size per arm for the cRCT is 39, with number of clusters per arm K=N/M =13, Considering a 10% attrition or exclusion rate, the target recruitment is 88 participants. Considering potential heterogeneity in baseline between students from the two schools, and possible contamination due to discussions among dormitory mates during the intervention, this study will adopt stratified cluster randomization, first stratifying by school, then using dormitory as the smallest randomization unit. Dormitories will be sorted by the random number, with the first half allocated to the intervention group and the second half to the control group. Participants' group assignment will be revealed via unique student ID only after baseline data collection and informed consent are completed. This study will select five topics from the "Comprehensive Clinical Course": "Infectious Diarrhea," "Viral Hepatitis," "Bloodstream Infection," "Infective Endocarditis," and "Central Nervous System Infection". Standardized cases will be provided by the teaching faculty, with two cases per topic, totaling 10 cases. These cases will be used to train AI agent. After class, the AI agent training tasks will be sent to the intervention group, and study materials will be distributed to the control group. Course examination scores and clinical reasoning test scores are the primary outcomes. AI technology acceptance including perceived usefulness, perceived ease of use, satisfaction, and intention to use are the secondary outcomes. This study has been approved by the Research Ethics Committee of Peking Union Medical College Hospital (Approval No.: I-26PJ0851).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Apr 2026Aug 2026

Study Start

First participant enrolled

April 1, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2026

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2026

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Expected
Last Updated

June 3, 2026

Status Verified

June 1, 2026

Enrollment Period

1 month

First QC Date

April 22, 2026

Last Update Submit

June 1, 2026

Conditions

Keywords

medical educationclinical reasoningAI agentAI-assisted education

Outcome Measures

Primary Outcomes (2)

  • Course examination scores

    The examination includes 8 of A1 multiple choice questions (MCQs), 8 of case summary MCQs, 2 of A3 case-cluster MCQs, 3 A4 case-series best-answer MCQs, and 1 of case analysis questions, with a total score of 25. All test questions are provided by the teaching faculty, covering core diseases from the five topics. The questions will reviewed by the same two senior clinical faculty members to ensure appropriate case selection and difficulty.

    One week after the course

  • Clinical reasoning test score

    The test is designed based on a case of infective endocarditis (IE) and is supposed to be accomplished in 30 min. There are five questions in total. Information and questions will be presented step by step, with a total score of 25.

    One month after the course

Secondary Outcomes (1)

  • AI technology acceptance

    Immediately after the clinical reasoning test

Study Arms (2)

intervention group (AI Agent)

EXPERIMENTAL
Other: AI agent

control group (study materials)

EXPERIMENTAL
Other: Study materials

Interventions

AI agent tasks for clinical reasoning training

intervention group (AI Agent)

Study materials including case information, questions, and answer keys

control group (study materials)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • full-time registered and enrolled in the "Comprehensive Clinical Course"
  • signed informed consent, voluntary participation in this study and completion of relevant tests and questionnaires

You may not qualify if:

  • · planned suspension of studies, withdrawal, or major transfer during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

Related Publications (3)

  • Leyrat C, Eldridge S, Taljaard M, Hemming K. Practical considerations for sample size calculation for cluster randomized trials. J Epidemiol Popul Health. 2024 Feb;72(1):202198. doi: 10.1016/j.jeph.2024.202198. Epub 2024 Feb 13.

    PMID: 38477482BACKGROUND
  • Miller GE. The assessment of clinical skills/competence/performance. Acad Med. 1990 Sep;65(9 Suppl):S63-7. doi: 10.1097/00001888-199009000-00045. No abstract available.

    PMID: 2400509BACKGROUND
  • Hopewell S, Chan AW, Collins GS, Hrobjartsson A, Moher D, Schulz KF, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari N, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne D, Farmer A, Fergusson DA, Golub RM, Goodman SN, Hoffmann TC, Ioannidis JPA, Kahan BC, Knowles RL, Lamb SE, Lewis S, Loder E, Offringa M, Ravaud P, Richards DP, Rockhold FW, Schriger DL, Siegfried NL, Staniszewska S, Taylor RS, Thabane L, Torgerson D, Vohra S, White IR, Boutron I. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025 Apr 14;389:e081123. doi: 10.1136/bmj-2024-081123.

    PMID: 40228833BACKGROUND

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 22, 2026

First Posted

June 3, 2026

Study Start

April 1, 2026

Primary Completion

May 8, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

June 3, 2026

Record last verified: 2026-06

Locations